CORO1C and colorectal carcinoma: The subsequent Kaplan–Meier survival analysis indicated that CRC patients with high CORO1C protein levels had shorter recurrence-free survival (RFS) times (P = 0.0075) but not overall survival times (P = 0.9171; Fig. 6).